Peter Haebel

1.4k total citations
24 papers, 1.1k citations indexed

About

Peter Haebel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Haebel has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Haebel's work include Endoplasmic Reticulum Stress and Disease (4 papers), Diabetes Treatment and Management (4 papers) and Neuropeptides and Animal Physiology (4 papers). Peter Haebel is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Diabetes Treatment and Management (4 papers) and Neuropeptides and Animal Physiology (4 papers). Peter Haebel collaborates with scholars based in Germany, New Zealand and Switzerland. Peter Haebel's co-authors include Peter Metcalf, Sascha Gutmann, Nenad Ban, Edward N. Baker, Vladimir Rybin, Andrew A. McCarthy, Anneli Törrönen, Keiko Ikeda, Elaine Chiu and Clemens Schulze‐Briese and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Peter Haebel

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Haebel Germany 16 832 236 191 164 98 24 1.1k
Shan Wu China 19 1.4k 1.6× 135 0.6× 106 0.6× 177 1.1× 97 1.0× 45 2.0k
Jay Painter United States 5 1.4k 1.7× 501 2.1× 135 0.7× 291 1.8× 115 1.2× 9 1.9k
L. Chantalat France 16 805 1.0× 172 0.7× 162 0.8× 106 0.6× 64 0.7× 27 1.2k
Ingo P. Korndörfer Germany 13 916 1.1× 367 1.6× 99 0.5× 141 0.9× 127 1.3× 14 1.3k
Todd Holyoak United States 20 935 1.1× 308 1.3× 137 0.7× 216 1.3× 51 0.5× 46 1.2k
E. Lucile White United States 20 819 1.0× 105 0.4× 144 0.8× 242 1.5× 30 0.3× 38 1.3k
Gerrit G. Langer Germany 5 1.1k 1.3× 451 1.9× 107 0.6× 196 1.2× 80 0.8× 8 1.5k
Federico M. Ruiz Spain 17 685 0.8× 88 0.4× 184 1.0× 85 0.5× 171 1.7× 34 978
Kyoung‐Seok Ryu South Korea 22 1.1k 1.3× 131 0.6× 206 1.1× 226 1.4× 54 0.6× 83 1.4k
Kai-Fa Huang Taiwan 21 689 0.8× 106 0.4× 86 0.5× 338 2.1× 107 1.1× 56 1.1k

Countries citing papers authored by Peter Haebel

Since Specialization
Citations

This map shows the geographic impact of Peter Haebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Haebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Haebel more than expected).

Fields of papers citing papers by Peter Haebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Haebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Haebel. The network helps show where Peter Haebel may publish in the future.

Co-authorship network of co-authors of Peter Haebel

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Haebel. A scholar is included among the top collaborators of Peter Haebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Haebel. Peter Haebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Augustin, Robert, Anouk Oldenburger, Jens Markus Borghardt, et al.. (2025). Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide. Molecular Metabolism. 99. 102205–102205. 1 indexed citations
3.
Baljuls, Angela, et al.. (2023). Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse model. Molecular Metabolism. 74. 101765–101765. 4 indexed citations
4.
Thomas, Leo, Peter Haebel, Eric J. Simon, et al.. (2022). BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy. Molecular Metabolism. 66. 101633–101633. 81 indexed citations
5.
Fox, Thomas, et al.. (2022). BILN: A Human-Readable Line Notation for Complex Peptides. Journal of Chemical Information and Modeling. 62(17). 3942–3947. 10 indexed citations
6.
Hansen, Henrik H., Peter Haebel, Harald Tammen, et al.. (2021). Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice. Scientific Reports. 11(1). 8060–8060. 10 indexed citations
7.
Wassermann, Anne Mai, Peter Haebel, Nils Weskamp, & Jürgen Bajorath. (2012). SAR Matrices: Automated Extraction of Information-Rich SAR Tables from Large Compound Data Sets. Journal of Chemical Information and Modeling. 52(7). 1769–1776. 43 indexed citations
8.
Wiesner, Jochen, Alexander Hillebrecht, Peter Haebel, et al.. (2008). Development of Benzophenone‐Based Farnesyltransferase Inhibitors as Novel Antimalarials. ChemMedChem. 3(8). 1217–1231. 28 indexed citations
9.
Coulibaly, Fasséli, Elaine Chiu, Keiko Ikeda, et al.. (2007). The molecular organization of cypovirus polyhedra. Nature. 446(7131). 97–101. 161 indexed citations
10.
Lübben, Mathias, Jörn Güldenhaupt, Martin Zoltner, et al.. (2007). Sulfate Acts as Phosphate Analog on the Monomeric Catalytic Fragment of the CPx-ATPase CopB from Sulfolobus solfataricus. Journal of Molecular Biology. 369(2). 368–385. 21 indexed citations
11.
Grimm, Clemens, et al.. (2006). Crystal structure of Bacillus subtilis S-adenosylmethionine:tRNA ribosyltransferase-isomerase. Biochemical and Biophysical Research Communications. 351(3). 695–701. 14 indexed citations
12.
Haebel, Peter, Sascha Gutmann, & Nenad Ban. (2004). Dial tm for rescue: tmRNA engages ribosomes stalled on defective mRNAs. Current Opinion in Structural Biology. 14(1). 58–65. 42 indexed citations
13.
Kettler, Katja, Jochen Wiesner, Peter Haebel, et al.. (2004). Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity. European Journal of Medicinal Chemistry. 40(1). 93–101. 15 indexed citations
14.
Walser, Piers J., Peter Haebel, Markus Künzler, et al.. (2004). Structure and Functional Analysis of the Fungal Galectin CGL2. Structure. 12(4). 689–702. 101 indexed citations
15.
Haebel, Peter, et al.. (2004). Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides. Bioorganic & Medicinal Chemistry. 12(17). 4585–4600. 15 indexed citations
16.
Gutmann, Sascha, Peter Haebel, Laurent Metzinger, et al.. (2003). Crystal structure of the transfer-RNA domain of transfer-messenger RNA in complex with SmpB. Nature. 424(6949). 699–703. 103 indexed citations
17.
18.
Haebel, Peter, Vickery L. Arcus, Edward N. Baker, & Peter Metcalf. (2001). LISA: an intranet-based flexible database for protein crystallography project management. Acta Crystallographica Section D Biological Crystallography. 57(9). 1341–1343. 11 indexed citations
19.
Haebel, Peter, et al.. (2001). Crystallization and Initial Crystallographic Analysis of the Disulfide Bond Isomerase DsbC in Complex with the α Domain of the Electron Transporter DsbD. Journal of Structural Biology. 136(2). 162–166. 17 indexed citations
20.
Metcalf, Peter, Andrew A. McCarthy, Peter Haebel, et al.. (2000). Crystal structure of the protein disulfide bond isomerase, DsbC, from Escherichia coli.. Nature Structural Biology. 7(3). 196–199. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shan Wu Breakdown of academic impact, for papers by Jay Painter Breakdown of academic impact, for papers by L. Chantalat Breakdown of academic impact, for papers by Ingo P. Korndörfer Breakdown of academic impact, for papers by Todd Holyoak Breakdown of academic impact, for papers by E. Lucile White Breakdown of academic impact, for papers by Gerrit G. Langer Breakdown of academic impact, for papers by Federico M. Ruiz Breakdown of academic impact, for papers by Kyoung‐Seok Ryu Breakdown of academic impact, for papers by Kai-Fa Huang
Rankless by CCL
2026